RecruitingNCT03413982

Bladder Cancer Longitudinal Biorepository for Development of Novel Therapeutics/Biomarkers

Sponsor

University of Kansas Medical Center

Enrollment

1,000 participants

Start Date

Nov 2, 2017

Study Type

OBSERVATIONAL

Conditions

Bladder Cancer

Summary

The purpose of this study is to create a registry, which is a "bank" of information about patients who have had similar medical conditions and treatments. The registry will be used by researchers to learn more about long term outcome of patients with bladder cancer, how bladder cancer tissues are related to tumor development, recurrence and survival.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is building a long-term collection of biological samples (such as blood, urine, and tissue) from bladder cancer patients to help researchers develop better treatments and tests for detecting and monitoring bladder cancer. **You may be eligible if...** - You have been diagnosed with bladder cancer, or bladder cancer is suspected and you are being evaluated - You are also allowed to participate in other related research studies at the same time **You may NOT be eligible if...** - You do not have a presumed or confirmed bladder cancer diagnosis Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.